1. Scrip
  2. >>Business
  3. >>Deals

Roche Dealmakers On The Immunology Technology They're Shopping For

 
• By Sue Sutter

Business development execs Patrick Schleck and Michael Crowley talk to Scrip about the company’s recent deals with Parvus, Jecure and Microbiotica in the inflammatory and autoimmune disease space.

Business handshake and business people on deal concept. vintage tone. - Image
Roche's dealmakers are looking for novel biologic approaches and technologies in the immunology space. • Source: Shutterstock

When Roche goes hunting for assets and partnerships in the immunology space, it does so with an eye toward novelty and versatility.

The big pharma believes it is well suited to leveraging promising new molecules and technology platforms

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business